Panel to study report on transgenic brinjal for approvalOctober 13th, 2009 BANGALORE - The genetic engineering approval committee (GEAC) under the environment and forests ministry will meet Wednesday to evaluate the safety and environment data on Bacillus Thuringiensis (Bt) brinjal for commercial release of the transgenic (GM) seed, a senior official said Tuesday. "A meeting has been convened Wednesday to discuss the report of the sub-committee and experts' views on the health safety and environmental issues of Bt brinjal," GEAC chairman B.S.
South Korean telecommunications regulator approves sale of Apple's iPhoneSeptember 22nd, 2009 South Korea approves sale of Apple's iPhoneSEOUL, South Korea — South Korea's telecommunications regulator said Wednesday it has given approval for Apple Inc.'s hit iPhone to be sold in the country — potentially shaking up a handset market controlled by domestic manufacturers. The Korea Communications Commission approved the sale of the device at a meeting attended by its five commissioners, said commission spokesman Lee Sang-hun.
Cardinal says it paid undisclosed amount for radiologic dye and scanning company BiotechAugust 3rd, 2009 Cardinal Health buys imaging company BiotechDUBLIN, Ohio — Cardinal Health Inc. said Monday it agreed to buy radiologic imaging company Biotech for an undisclosed amount.
Emami Biotech to invest $80 mn in EthiopiaAugust 3rd, 2009 KOLKATA - Emami Biotech, belonging to the Rs.2,000-crore Emami group, will invest Rs.400 crore (around $80 million) in a jatropha plantation project in Oromia in Ethiopia over the next six years, a top company official said here Monday. "We have already acquired around 30,000 acres and work has begun for jatropha cultivation.
Pfizer pulls out of plan to move biotech workers to San Francisco facilityJuly 7th, 2009 Pfizer ends plan San Francisco biotech facilityNEW YORK — Pfizer Inc. is pulling a plan to staff a biotechnology research center in San Francisco and will keep its 100 area employees in South San Francisco.
Geithner: Federal Reserve is best suited to be super financial regulatorJune 18th, 2009 Geithner: Fed best suited for super regulator roleWASHINGTON — Treasury Secretary Timothy Geithner says the Federal Reserve is best suited to become a super-regulator that would oversee financial firms so big and influential that their failure could topple the economy. Some lawmakers want to give the job to a council of regulators.
Indian biotech industry growing, but at slower paceJune 18th, 2009 BANGALORE - Global recession and slowdown in the domestic market impacted the Indian biotech industry last fiscal, resulting in a year-on-year (YoY) growth declining to 18 percent from 34 percent notched in 2007-08. According to data released Thursday at Bangalore Bio 2009, India's premier biotech event, the industry grew to Rs.12,137 crore from Rs.10,274 crore the previous fiscal, reflecting an increase of 18 percent.
Regulator for Indian biotech industry on anvilJune 18th, 2009 BANGALORE - India will soon have a regulatory authority for the biotech sector, Minister of State for Science and Technology Prithviraj Chavan said here Thursday. "We are setting up a national biotechnology regulatory authority in partnership with the industry," Chavan said, unveiling the ninth edition of Bangalore Bio 2009, South Asia' premier biotech event that has attracted 110 firms from 15 countries apart from India.
Insurance regulator may issue 'embedded value' normsJune 11th, 2009 KOLKATA - The country's insurance regulator may issue norms for estimating "embedded value" of future insurance premiums by August, a top official said here Wednesday. "The guidance note is ready and it would be issued within two months," J.
FTC pans biotech demands on generic competition, says would discourage development of new medsJune 11th, 2009 FTC pans biotech demands for generic competitionWASHINGTON — The biotechnology industry's demand for up to 14 years of competition-free marketing before cheaper copies of their drugs can be launched is unnecessary and would discourage development of new treatments, the Federal Trade Commission told lawmakers Thursday. As the administration accelerates its push to reform U.S.
Waxman pushes Obama administration for early action to lower biotech drug costsJune 8th, 2009 Top Democrat pushes for action on biotech drugsWASHINGTON — As the Obama administration renews its health care reform effort on Capitol Hill, a top Democrat is calling for speedy action on a yearslong effort to create generic competition for costly biotech drugs. President Barack Obama used his weekly radio address on Saturday to call on Congress to act on his proposal to overhaul the nation's health care system.
Obama to name South Carolina utility regulator to open chair at FCCApril 30th, 2009 Obama to name SC regulator to FCC seatPresident Barack Obama intends to nominate Mignon Clyburn, a utility regulator and former newspaper executive from South Carolina, to the Federal Communications Commission. The five-member FCC has three vacancies.
Biotech rice to be commercially available in India by 2012February 25th, 2009 NEW DELHI - The much awaited biotech rice, the insect-resistant variety with high nutritional value, will be commercially available in India only by 2011-12, scientists said here Tuesday. 'The polished rice we generally consume does not have iron content as its pulp is removed.
Airlines reply to regulator on fare hikeFebruary 13th, 2009 NEW DELHI - The aviation regulator has got explanation letters from six airlines on why they withdrew promotional fares and hiked base tariff, a government official said here Saturday. He refused to divulge details of the letters.
Regulator eases solvency norms for life insurersJanuary 1st, 2009 CHENNAI - India's insurance watchdog Friday offered life insurers, and more particularly the private life insurers, a mega New Year gift by easing solvency norms for the third time in recent days. Solvency margin is the excess of assets that a life insurer has to maintain over its liabilities.